Product Information
CROMOLYN 20 MG/2 ML NEB SOLN is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.9626 per ML under NDC 00172640649. Its NADAC has been published 348 times since Nov 28, 2013.
FDA first approved this application on Jan 18, 2000. Its Orange Book therapeutic-equivalence code is AN.
Strength
20 mg/2mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00172640649
Classification
Generic
Dosage Form
SOLUTION
Route
INTRABRONCHIAL
Effective Date
9/23/2026
Active Ingredients
CROMOLYN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA075271FDA Approved
1/18/2000
TE Code
AN
On Market Since
1/18/2000
Pharmacological Classes
Price Statistics
The NADAC for CROMOLYN 20 MG/2 ML NEB SOLN has been published 348 times since Nov 28, 2013, and over the history we have for it it has risen 21.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9626 per ML |
|---|---|
| All-time high | $2.0247 (Aug 14, 2024) |
| All-time low | $0.5505 (Jun 18, 2025) |
| 52-week high | $1.0554 |
| 52-week low | $0.5662 |
| Median price | $1.3113 |
| Average price | $1.2402 |
| Largest weekly change | +66.0% (Jan 21, 2015) |
| Weeks tracked | 348 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cromolyn Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cromolyn Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mast Cell Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CROMOLYN 20 MG/2 ML NEB SOLN?
The current National Average Drug Acquisition Cost (NADAC) for CROMOLYN 20 MG/2 ML NEB SOLN, manufactured by Teva Pharmaceuticals USA Inc., is $0.9626 per ML (NDC 00172640649), effective Sep 30, 2026.
How has the price of CROMOLYN 20 MG/2 ML NEB SOLN changed over time?
Over the history we have for it, the NADAC for CROMOLYN 20 MG/2 ML NEB SOLN has risen 21.9%. It has been tracked across 348 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CROMOLYN 20 MG/2 ML NEB SOLN?
Since Nov 28, 2013, the NADAC for CROMOLYN 20 MG/2 ML NEB SOLN has ranged from a low of $0.5505 (Jun 18, 2025) to a high of $2.0247 (Aug 14, 2024), with a median of $1.3113 per ML.
Are there cheaper alternatives to CROMOLYN 20 MG/2 ML NEB SOLN?
No other NADAC-published product currently shares the active ingredient and strength of CROMOLYN 20 MG/2 ML NEB SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CROMOLYN 20 MG/2 ML NEB SOLN?
CROMOLYN 20 MG/2 ML NEB SOLN (NDC 00172640649) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.